These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7696172)

  • 1. Docetaxel and radiation-recall severe mucositis.
    Zulian GB; Aapro MS
    Ann Oncol; 1994 Dec; 5(10):964. PubMed ID: 7696172
    [No Abstract]   [Full Text] [Related]  

  • 2. Challenges in oncology. Case 2. Radiation recall associated with docetaxel.
    Morkas M; Fleming D; Hahl M
    J Clin Oncol; 2002 Feb; 20(3):867-9. PubMed ID: 11821473
    [No Abstract]   [Full Text] [Related]  

  • 3. Radiation-recall dermatitis with docetaxel: establishment of a requisite radiation threshold.
    Yeo W; Leung SF; Johnson PJ
    Eur J Cancer; 1997 Apr; 33(4):698-9. PubMed ID: 9274459
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase I study of weekly docetaxel infusion and concurrent radiation therapy for head and neck cancer.
    Suzuki M; Nishimura Y; Nakamatsu K; Kanamori S; Koike R; Kawamoto M; Mori K
    Jpn J Clin Oncol; 2003 Jun; 33(6):297-301. PubMed ID: 12913084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation of seborrheic keratoses due to docetaxel treatment.
    Chu CY; Yang CH; Chiu HC
    Acta Derm Venereol; 2001; 81(4):316-7. PubMed ID: 11720193
    [No Abstract]   [Full Text] [Related]  

  • 6. Epiphora induced by intermittent docetaxel (taxotere) in patients with non-small cell lung cancer.
    Spell DW; Estephan FF; Lin JT; Jones DV
    Cancer Invest; 2003; 21(4):550-2. PubMed ID: 14533445
    [No Abstract]   [Full Text] [Related]  

  • 7. Reversible hepatic coma possibly induced by docetaxel treatment.
    Chen YM; Tsai CM; Perng RP
    Lung Cancer; 2001; 31(2-3):347-8. PubMed ID: 11305259
    [No Abstract]   [Full Text] [Related]  

  • 8. Concurrent twice-a-week docetaxel and radiotherapy: a dose escalation trial with immunological toxicity evaluation.
    Koukourakis MI; Giatromanolaki A; Schiza S; Kakolyris S; Georgoulias V
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):107-14. PubMed ID: 9989521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of docetaxel (taxotere) in patients with previously untreated extensive small cell lung cancer.
    Latreille J; Cormier Y; Martins H; Goss G; Fisher B; Eisenhauer EA
    Invest New Drugs; 1996; 13(4):343-5. PubMed ID: 8824354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel and interstitial pulmonary injury.
    Merad M; Le Cesne A; Baldeyrou P; Mesurolle B; Le Chevalier T
    Ann Oncol; 1997 Feb; 8(2):191-4. PubMed ID: 9093730
    [No Abstract]   [Full Text] [Related]  

  • 11. Docetaxel-induced radiation recall dermatitis and successful rechallenge without recurrence.
    Camidge DR; Kunkler IH
    Clin Oncol (R Coll Radiol); 2000; 12(4):272-3. PubMed ID: 11005698
    [No Abstract]   [Full Text] [Related]  

  • 12. [Recall dermatitis caused by re-exposure to docetaxel following irradiation of the brain. Case report and review of the literature].
    Giesel BU; Kutz GG; Thiel HJ
    Strahlenther Onkol; 2001 Sep; 177(9):487-93. PubMed ID: 11591023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Typhlitis associated with docetaxel treatment.
    Cardenal F; Montes A; Llort G; Seguí J; Mesía R
    J Natl Cancer Inst; 1996 Aug; 88(15):1078-9. PubMed ID: 8683639
    [No Abstract]   [Full Text] [Related]  

  • 14. Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma.
    Koukourakis MI; Bahlitzanakis N; Froudarakis M; Giatromanolaki A; Georgoulias V; Koumiotaki S; Christodoulou M; Kyrias G; Skarlatos J; Kostantelos J; Beroukas K
    Br J Cancer; 1999 Aug; 80(11):1792-6. PubMed ID: 10468298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of docetaxel (Taxotere) in non-small cell lung cancer.
    Kris MG; Miller VA; Ng KK; Grant SC
    Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-1-S14-4. PubMed ID: 9335515
    [No Abstract]   [Full Text] [Related]  

  • 16. Squamous syringometaplasia associated with docetaxel.
    Karam A; Metges JP; Labat JP; Leroy JP; Guillet G
    Br J Dermatol; 2002 Mar; 146(3):524-5. PubMed ID: 11952559
    [No Abstract]   [Full Text] [Related]  

  • 17. Paclitaxel (Taxol) and docetaxel (Taxotere): active chemotherapeutic agents in lung cancer.
    Francis PA; Kris MG; Rigas JR; Grant SC; Miller VA
    Lung Cancer; 1995 Apr; 12 Suppl 1():S163-72. PubMed ID: 7551925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined irinotecan, docetaxel and conventionally fractionated radiotherapy in locally advanced head and neck cancer. A phase I dose escalation study.
    Koukourakis MI; Bizakis JG; Skoulakis CE; Kyrmizakis D; Giatromanolaki A; Papadakis CE; Prokopakis E; Amanakis Z; Hellidonis ES
    Anticancer Res; 1999; 19(3B):2305-9. PubMed ID: 10472349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe syndrome of inappropriate antidiuretic hormone secretion with docetaxel treatment in metastatic breast cancer.
    Langer-Nitsche C; Lück HJ; Heilmann M
    Acta Oncol; 2000; 39(8):1001. PubMed ID: 11206991
    [No Abstract]   [Full Text] [Related]  

  • 20. Nail toxicity related to taxanes.
    Mourad YA; Matta-Muallem M; Shamseddine A
    Dermatol Online J; 2003 Aug; 9(3):15. PubMed ID: 12952762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.